awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38710873-33959832-6948-4D74-B72E-D346B8C008FE
Q38710873-33959832-6948-4D74-B72E-D346B8C008FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38710873-33959832-6948-4D74-B72E-D346B8C008FE
Pasireotide for the treatment of acromegaly.
P2860
Q38710873-33959832-6948-4D74-B72E-D346B8C008FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38710873-33959832-6948-4D74-B72E-D346B8C008FE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11f6bfb274c235cf094918c66557119a434632f9
P2860
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study.